IFNA13 抗体 (C-Term)
Quick Overview for IFNA13 抗体 (C-Term) (ABIN926586)
抗原
See all IFNA13 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- C-Term
- 
                                            纯化方法
- Purified
- 
                                            免疫原
- IFNA13 antibody was raised in rabbit using the C terminal of IFNA13 as the immunogen
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal conditions should be determined by the investigator.
- 
                                            说明
- 
                        IFNA13 Blocking Peptide, (ABIN939424), is also available for use as a blocking control in assays to test for specificity of this IFNA13 antibody 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- 
                                            注意事项
- Avoid repeated freeze/thaw cycles.
- 
                                            储存条件
- 4 °C/-20 °C
- 
                                            储存方法
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
 
- 
                                            
- 
    - IFNA13 (Interferon, alpha 13 (IFNA13))
- 
                                            别名
- IFNA13
- 
                                            背景
- IFNA13 is produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. Synonyms: Polyclonal IFNA13 antibody, Anti-IFNA13 antibody, interferon, alpha 13 antibody, IFNA1 antibody.
- 
                                            途径
- JAK/STAT Signaling, Hepatitis C
 抗原
- 
                    
 
                                     
                                     
                                    